Clinical Trial Update: Study of Transplant Related Anemia Treated With Aranesp® (STRATA) [Phase 4]

View source ↗

Summary

This Phase 4 trial (STRATA) evaluating Aranesp for transplant-related anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)

Snippet

Sponsor: Amgen | Conditions: Anemia | Phase 4 | Status: COMPLETED